{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T19:08:12Z","timestamp":1791313692355,"version":"4.3.1"},"reference-count":57,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"name":"Stichting Technologische Wetenschap","award":["12064"],"award-info":[{"award-number":["12064"]}]},{"DOI":"10.13039\/501100004622","name":"Koningin Wilhelmina Fonds","doi-asserted-by":"crossref","award":["10666"],"award-info":[{"award-number":["10666"]}],"id":[{"id":"10.13039\/501100004622","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Stichting Nationaal Fonds Tegen Kanker in Amsterdam","award":["SNFKHeger2009"],"award-info":[{"award-number":["SNFKHeger2009"]}]},{"name":"Stichting Nationaal Fonds Tegen Kanker in Amsterdam","award":["SNFKHeger2012"],"award-info":[{"award-number":["SNFKHeger2012"]}]},{"name":"Phospholipid Research Center in Heidelberg","award":["PRCHeger2012"],"award-info":[{"award-number":["PRCHeger2012"]}]},{"name":"Phospholipid Research Center in Heidelberg","award":["NMSHeger2010"],"award-info":[{"award-number":["NMSHeger2010"]}]},{"name":"Nijbakker-Morra Foundation in Leiden"},{"name":"Medical Research Council and National Institute for Health Research","award":["MC_PC_12025"],"award-info":[{"award-number":["MC_PC_12025"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"],"published-print":{"date-parts":[[2018,3]]},"DOI":"10.1016\/j.bbadis.2017.11.022","type":"journal-article","created":{"date-parts":[[2017,11,29]],"date-time":"2017-11-29T05:45:53Z","timestamp":1511934353000},"page":"942-951","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["The pathophysiology of human obstructive cholestasis is mimicked in cholestatic Gold Syrian hamsters"],"prefix":"10.1016","volume":"1864","author":[{"given":"Rowan F.","family":"van Golen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pim B.","family":"Olthof","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lianne R.","family":"de Haan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert J.","family":"Coelen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandros","family":"Pechlivanis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark J.","family":"de Keijzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruud","family":"Weijer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dirk R.","family":"de Waart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9 B.P.","family":"van Kuilenburg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeroen","family":"Roelofsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pim W.","family":"Gilijamse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martinus A.","family":"Maas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew R.","family":"Lewis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeremy K.","family":"Nicholson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanne","family":"Verheij","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michal","family":"Heger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.bbadis.2017.11.022_bb0005","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.cld.2012.12.004","article-title":"Alagille syndrome and other hereditary causes of cholestasis","volume":"17","author":"Hartley","year":"2013","journal-title":"Clin Liver Dis"},{"issue":"7","key":"10.1016\/j.bbadis.2017.11.022_bb0010","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1053\/j.gastro.2013.03.053","article-title":"The genetics of complex cholestatic disorders","volume":"144","author":"Hirschfield","year":"2013","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1016\/j.bbadis.2017.11.022_bb0015","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1002\/hep.28401","article-title":"Cholangiocarcinoma (CCA)","volume":"63","author":"Rizvi","year":"2015","journal-title":"Hepatology"},{"issue":"Suppl. 1","key":"10.1016\/j.bbadis.2017.11.022_bb0020","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1111\/liv.13306","article-title":"Management of cholestatic disease in 2017","volume":"37","author":"de Vries","year":"2017","journal-title":"Liver Int."},{"issue":"7","key":"10.1016\/j.bbadis.2017.11.022_bb0025","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1056\/NEJMoa1509840","article-title":"A placebo-controlled trial of obeticholic acid in primary biliary cholangitis","volume":"375","author":"Nevens","year":"2016","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.bbadis.2017.11.022_bb0030","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.jhep.2013.09.019","article-title":"Time to say goodbye to the drug or the model? - why do drugs fail to live up to their promise in bile duct ligated mice?","volume":"60","author":"Fickert","year":"2014","journal-title":"J. Hepatol."},{"issue":"8","key":"10.1016\/j.bbadis.2017.11.022_bb0035","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1038\/nrd2619","article-title":"Targeting bile-acid signalling for metabolic diseases","volume":"7","author":"Thomas","year":"2008","journal-title":"Nat. Rev. Drug Discov."},{"issue":"2","key":"10.1016\/j.bbadis.2017.11.022_bb0040","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.cmet.2013.01.003","article-title":"Gut microbiota regulates bile acid metabolism by reducing the levels of tauro-beta-muricholic acid, a naturally occurring FXR antagonist","volume":"17","author":"Sayin","year":"2013","journal-title":"Cell Metab."},{"issue":"4","key":"10.1016\/j.bbadis.2017.11.022_bb0045","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1002\/hep.26133","article-title":"Defective bile salt biosynthesis and hydroxylation in mice with reduced cytochrome P450 activity","volume":"57","author":"Kunne","year":"2013","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.bbadis.2017.11.022_bb0050","doi-asserted-by":"crossref","DOI":"10.1053\/j.gastro.2015.05.043","article-title":"Fibroblast growth factor signaling controls liver size in mice with humanized livers","volume":"149","author":"Naugler","year":"2015","journal-title":"Gastroenterology"},{"issue":"5","key":"10.1016\/j.bbadis.2017.11.022_bb0055","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1016\/j.physbeh.2011.06.006","article-title":"Social stress and reproductive success in the female Syrian hamster: endocrine and behavioral correlates","volume":"104","author":"Chelini","year":"2011","journal-title":"Physiol. Behav."},{"issue":"2","key":"10.1016\/j.bbadis.2017.11.022_bb0060","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1093\/infdis\/jis626","article-title":"A syrian golden hamster model recapitulating ebola hemorrhagic fever","volume":"207","author":"Ebihara","year":"2013","journal-title":"J. Infect. Dis."},{"issue":"11","key":"10.1016\/j.bbadis.2017.11.022_bb0065","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1194\/jlr.M016410","article-title":"Anacetrapib promotes reverse cholesterol transport and bulk cholesterol excretion in syrian golden hamsters","volume":"52","author":"Castro-Perez","year":"2011","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.bbadis.2017.11.022_bb0070","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1186\/1471-2164-14-237","article-title":"High throughput transcriptome analysis of lipid metabolism in Syrian hamster liver in absence of an annotated genome","volume":"14","author":"Schmucki","year":"2013","journal-title":"BMC Genomics"},{"issue":"1","key":"10.1016\/j.bbadis.2017.11.022_bb0075","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.tig.2015.10.001","article-title":"Transmissible tumors: breaking the cancer paradigm","volume":"32","author":"Ostrander","year":"2016","journal-title":"Trends Genet."},{"issue":"11","key":"10.1016\/j.bbadis.2017.11.022_bb0080","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0112617","article-title":"Sequencing, annotation and analysis of the Syrian hamster (mesocricetus auratus) transcriptome","volume":"9","author":"Tchitchek","year":"2014","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.bbadis.2017.11.022_bb0085","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1194\/jlr.M033423","article-title":"Differential regulation of bile acid and cholesterol metabolism by the farnesoid X receptor in ldlr \u2212\/\u2212 mice versus hamsters","volume":"54","author":"Gard\u00e8s","year":"2013","journal-title":"J. Lipid Res."},{"issue":"2","key":"10.1016\/j.bbadis.2017.11.022_bb0090","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0925-4439(02)00157-6","article-title":"Selective inhibition of CYP27A1 and of chenodeoxycholic acid synthesis in cholestatic hamster liver","volume":"1588","author":"Matsuzaki","year":"2002","journal-title":"Biochim. Biophys. Acta"},{"issue":"1","key":"10.1016\/j.bbadis.2017.11.022_bb0095","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0022-2275(20)39589-4","article-title":"Bile acids in the rat: studies in experimental occlusion of the bile duct","volume":"7","author":"Boyd","year":"1966","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.bbadis.2017.11.022_bb0100","doi-asserted-by":"crossref","DOI":"10.1038\/srep31829","article-title":"Simple steatosis sensitizes cholestatic rats to liver injury and dysregulates bile salt synthesis and transport","volume":"6","author":"Lionarons","year":"2016","journal-title":"Sci. Rep."},{"issue":"19","key":"10.1016\/j.bbadis.2017.11.022_bb0105","doi-asserted-by":"crossref","first-page":"9662","DOI":"10.1021\/acs.analchem.5b01556","article-title":"Bile acid profiling and quantification in biofluids using ultra-performance liquid chromatography tandem mass spectrometry","volume":"87","author":"Sarafian","year":"2015","journal-title":"Anal. Chem."},{"issue":"10","key":"10.1016\/j.bbadis.2017.11.022_bb0110","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1039\/b604498k","article-title":"A pragmatic and readily implemented quality control strategy for HPLC-MS and gc-ms-based metabonomic analysis","volume":"131","author":"Sangster","year":"2006","journal-title":"Analyst"},{"issue":"3","key":"10.1016\/j.bbadis.2017.11.022_bb0115","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1042\/bj2250787","article-title":"Reverse-phase h.P.L.C. Separation, quantification and preparation of bilirubin and its conjugates from native bile. Quantitative analysis of the intact tetrapyrroles based on h.P.L.C. Of their ethyl anthranilate azo derivatives","volume":"225","author":"Spivak","year":"1985","journal-title":"Biochem. J."},{"issue":"2","key":"10.1016\/j.bbadis.2017.11.022_bb0120","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1172\/JCI59526","article-title":"Complete OATP1B1 and OATP1B3 deficiency causes human rotor syndrome by interrupting conjugated bilirubin reuptake into the liver","volume":"122","author":"van de Steeg","year":"2012","journal-title":"J. Clin. Invest."},{"issue":"8","key":"10.1016\/j.bbadis.2017.11.022_bb0125","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1016\/S0006-2952(01)00756-0","article-title":"The cytostatic- and differentiation-inducing effects of cyclopentenyl cytosine on neuroblastoma cell lines","volume":"62","author":"Bierau","year":"2001","journal-title":"Biochem. Pharmacol."},{"issue":"3","key":"10.1016\/j.bbadis.2017.11.022_bb0130","first-page":"180","article-title":"IL-23 and IL-17 are not involved in hepatic ischemia reperfusion injury in mouse and man","volume":"1","author":"Olthof","year":"2015","journal-title":"J Clin Transl Res"},{"key":"10.1016\/j.bbadis.2017.11.022_bb0135","doi-asserted-by":"crossref","first-page":"516","DOI":"10.2119\/molmed.2014.00057","article-title":"Reduction of cardiac cell death after helium postconditioning in rats: transcriptional analysis of cell death and survival pathways","volume":"20","author":"Oei","year":"2014","journal-title":"Mol. Med."},{"issue":"3","key":"10.1016\/j.bbadis.2017.11.022_bb0140","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/S0016-5085(03)01068-0","article-title":"Role of farnesoid X receptor in determining hepatic ABC transporter expression and liver injury in bile duct-ligated mice","volume":"125","author":"Wagner","year":"2003","journal-title":"Gastroenterology"},{"issue":"3","key":"10.1016\/j.bbadis.2017.11.022_bb0145","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.jhep.2004.10.016","article-title":"Oncosis represents the main type of cell death in mouse models of cholestasis","volume":"42","author":"Fickert","year":"2005","journal-title":"J. Hepatol."},{"issue":"8","key":"10.1016\/j.bbadis.2017.11.022_bb0150","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1089\/ars.2011.4291","article-title":"Cholestasis is associated with hepatic microvascular dysfunction and aberrant energy metabolism before and during ischemia-reperfusion","volume":"17","author":"Kloek","year":"2012","journal-title":"Antioxid. Redox Signal."},{"issue":"5","key":"10.1016\/j.bbadis.2017.11.022_bb0155","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1002\/bjs.6050","article-title":"Characterization of time-related changes after experimental bile duct ligation","volume":"95","author":"Georgiev","year":"2008","journal-title":"Br. J. Surg."},{"issue":"6","key":"10.1016\/j.bbadis.2017.11.022_bb0160","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1016\/j.humpath.2012.09.017","article-title":"Evaluation of a new histologic staging and grading system for primary biliary cirrhosis in comparison with classical systems","volume":"44","author":"Kakuda","year":"2013","journal-title":"Hum. Pathol."},{"issue":"2","key":"10.1016\/j.bbadis.2017.11.022_bb0165","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1111\/j.1365-2559.2011.03853.x","article-title":"Inflammatory disease of the bile ducts-cholangiopathies: liver biopsy challenge and clinicopathological correlation","volume":"60","author":"Portmann","year":"2012","journal-title":"Histopathology"},{"issue":"Suppl. 2","key":"10.1016\/j.bbadis.2017.11.022_bb0170","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1111\/den.12060","article-title":"Unilateral versus bilateral endoscopic biliary stenting for malignant hilar biliary strictures","volume":"25","author":"Yasuda","year":"2013","journal-title":"Dig. Endosc."},{"issue":"12","key":"10.1016\/j.bbadis.2017.11.022_bb0175","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1055\/s-0034-1392559","article-title":"Preoperative biliary drainage in perihilar cholangiocarcinoma: identifying patients who require percutaneous drainage after failed endoscopic drainage","volume":"47","author":"Wiggers","year":"2015","journal-title":"Endoscopy"},{"issue":"12","key":"10.1016\/j.bbadis.2017.11.022_bb0180","doi-asserted-by":"crossref","first-page":"3338","DOI":"10.1111\/ajt.13963","article-title":"Transplantation and damage-associated molecular patterns (damps)","volume":"16","author":"Land","year":"2016","journal-title":"Am. J. Transplant."},{"issue":"3","key":"10.1016\/j.bbadis.2017.11.022_bb0185","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.taap.2015.01.015","article-title":"Bile acid-induced necrosis in primary human hepatocytes and in patients with obstructive cholestasis","volume":"283","author":"Woolbright","year":"2015","journal-title":"Toxicol. Appl. Pharmacol."},{"issue":"4","key":"10.1016\/j.bbadis.2017.11.022_bb0190","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1002\/hep.22771","article-title":"High expression of the bile salt-homeostatic hormone fibroblast growth factor 19 in the liver of patients with extrahepatic cholestasis","volume":"49","author":"Schaap","year":"2009","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.bbadis.2017.11.022_bb0195","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1111\/j.1478-3231.2011.02662.x","article-title":"Effect of bile duct ligation on bile acid composition in mouse serum and liver","volume":"32","author":"Zhang","year":"2012","journal-title":"Liver Int."},{"issue":"4","key":"10.1016\/j.bbadis.2017.11.022_bb0200","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1016\/0016-5085(95)90585-5","article-title":"Generation of hydroperoxides in isolated rat hepatocytes and hepatic mitochondria exposed to hydrophobic bile acids","volume":"109","author":"Sokol","year":"1995","journal-title":"Gastroenterology"},{"issue":"3","key":"10.1016\/j.bbadis.2017.11.022_bb0205","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1172\/JCI108821","article-title":"Bile acid excretion: the alternate pathway in the hamster","volume":"60","author":"Galeazzi","year":"1977","journal-title":"J. Clin. Invest."},{"issue":"2","key":"10.1016\/j.bbadis.2017.11.022_bb0210","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1093\/toxsci\/kfn268","article-title":"Bile acid sulfation: a pathway of bile acid elimination and detoxification","volume":"108","author":"Alnouti","year":"2009","journal-title":"Toxicol. Sci."},{"issue":"5","key":"10.1016\/j.bbadis.2017.11.022_bb0215","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1007\/BF01313580","article-title":"Altered bile acid metabolism in primary biliary cirrhosis","volume":"26","author":"Raedsch","year":"1981","journal-title":"Dig. Dis. Sci."},{"issue":"3","key":"10.1016\/j.bbadis.2017.11.022_bb0220","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1002\/hep.1840050325","article-title":"Biliary and urinary excretion of sulfated, glucuronidated and tetrahydroxylated bile acids in cirrhotic patients","volume":"5","author":"Stiehl","year":"1985","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.bbadis.2017.11.022_bb0225","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1055\/s-2000-9426","article-title":"Hepatic transport of bile salts","volume":"20","author":"Kullak-Ublick","year":"2000","journal-title":"Semin. Liver Dis."},{"issue":"1","key":"10.1016\/j.bbadis.2017.11.022_bb0230","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1093\/toxsci\/57.1.177","article-title":"Bile acids affect liver mitochondrial bioenergetics: possible relevance for cholestasis therapy","volume":"57","author":"Rolo","year":"2000","journal-title":"Toxicol. Sci."},{"issue":"1","key":"10.1016\/j.bbadis.2017.11.022_bb0235","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1093\/toxsci\/kfh078","article-title":"Role of mitochondrial dysfunction in combined bile acid-induced cytotoxicity: the switch between apoptosis and necrosis","volume":"79","author":"Rolo","year":"2004","journal-title":"Toxicol. Sci."},{"issue":"2","key":"10.1016\/j.bbadis.2017.11.022_bb0240","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1124\/jpet.104.079665","article-title":"Protective effects of 6-ethyl chenodeoxycholic acid, a farnesoid X receptor ligand, in estrogen-induced cholestasis","volume":"313","author":"Fiorucci","year":"2005","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"2","key":"10.1016\/j.bbadis.2017.11.022_bb0245","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.cmet.2014.05.020","article-title":"Cytoplasmic tyrosine phosphatase shp2 coordinates hepatic regulation of bile acid and FGF15\/19 signaling to repress bile acid synthesis","volume":"20","author":"Li","year":"2014","journal-title":"Cell Metab."},{"issue":"247","key":"10.1016\/j.bbadis.2017.11.022_bb0250","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3009098","article-title":"A nontumorigenic variant of FGF19 treats cholestatic liver diseases","volume":"6","author":"Luo","year":"2014","journal-title":"Sci. Transl. Med."},{"issue":"3","key":"10.1016\/j.bbadis.2017.11.022_bb0255","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1002\/hep.28257","article-title":"Engineered FGF19 reduces liver injury and resolves sclerosing cholangitis in mdr2-deficient mice","volume":"63","author":"Zhou","year":"2015","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.bbadis.2017.11.022_bb0260","doi-asserted-by":"crossref","DOI":"10.1053\/j.gastro.2011.10.028","article-title":"Selective activation of nuclear bile acid receptor FXR in the intestine protects mice against cholestasis","volume":"142","author":"Modica","year":"2012","journal-title":"Gastroenterology"},{"issue":"12","key":"10.1016\/j.bbadis.2017.11.022_bb0265","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0014412","article-title":"The receptor tyrosine kinase FGFR4 negatively regulates nf-kappab signaling","volume":"5","author":"Drafahl","year":"2010","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.bbadis.2017.11.022_bb0270","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1002\/hep.22627","article-title":"Bile acids activate fibroblast growth factor 19 signaling in human hepatocytes to inhibit cholesterol 7alpha-hydroxylase gene expression","volume":"49","author":"Song","year":"2009","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.bbadis.2017.11.022_bb0275","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1002\/hep.24702","article-title":"The human gallbladder secretes fibroblast growth factor 19 into bile: towards defining the role of fibroblast growth factor 19 in the enterobiliary tract","volume":"55","author":"Zweers","year":"2012","journal-title":"Hepatology"},{"issue":"10","key":"10.1016\/j.bbadis.2017.11.022_bb0280","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1136\/gutjnl-2016-312975","article-title":"Fibroblast growth factor 15\/19 (FGF15\/19) protects from diet-induced hepatic steatosis: development of an fgf19-based chimeric molecule to promote fatty liver regeneration","volume":"66","author":"Alvarez-Sola","year":"2017","journal-title":"Gut"},{"issue":"6","key":"10.1016\/j.bbadis.2017.11.022_bb0285","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1136\/gutjnl-2012-302945","article-title":"Identification of fibroblast growth factor 15 as a novel mediator of liver regeneration and its application in the prevention of post-resection liver failure in mice","volume":"62","author":"Uriarte","year":"2013","journal-title":"Gut"}],"container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0925443917304441?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0925443917304441?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,8,9]],"date-time":"2022-08-09T15:37:59Z","timestamp":1660059479000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0925443917304441"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3]]},"references-count":57,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,3]]}},"alternative-id":["S0925443917304441"],"URL":"https:\/\/doi.org\/10.1016\/j.bbadis.2017.11.022","relation":{},"ISSN":["0925-4439"],"issn-type":[{"value":"0925-4439","type":"print"}],"subject":[],"published":{"date-parts":[[2018,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The pathophysiology of human obstructive cholestasis is mimicked in cholestatic Gold Syrian hamsters","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbadis.2017.11.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V.","name":"copyright","label":"Copyright"}]}}